CHICAGO--(BUSINESS WIRE)--Fitch Ratings has assigned a 'BBB-' rating to $79 million (including premium) of series 2016 fixed rate revenue bonds expected to be issued by the Calhoun County (MI) Hospital Finance Authority on behalf of Oaklawn Hospital (Oaklawn).
Bond proceeds will refund Oaklawn's series 2009A&B and series 2010A bonds and term loans (which represent essentially all of Oaklawn's current debt outstanding), provide funds to finance capital projects, provide funds to terminate Oaklawn's swaps, and pay the costs of issuance. The bonds are expected to price the week of Oct. 17 via negotiation.
The Rating Outlook is Stable.
SECURITY
Debt payments are to be secured by a gross revenue pledge of the obligated group. Oaklawn's main receipts account will be subject to an account control agreement that will facilitate the Master Trustee's ability to gain control over the gross revenue upon the occurrence of certain events of default. A mortgage pledge is also included on Oaklawn's acute care hospital in Marshall, MI. A debt service reserve fund (DSRF) is not expected.
KEY RATING DRIVERS
NICE REBOUND IN OPERATING MARGINS IN FISCAL 2015 AND 2016: Under new management, Oaklawn's operating margins improved noticeably in fiscal 2015 (11.3% operating EBITDA margin) and fiscal 2016 (10.8%) after operating losses in fiscal 2013 and 2014. Even during the down years, Oaklawn's operating EBITDA margin remained sound relative to other 'BBB-' credits.
ADEQUATE DEBT RATIOS: Oaklawn's pro forma debt ratios are adequate, with 3.0x maximum annual debt service (MADS) coverage and 4.0% MADS-to-total revenue.
LIMITED DEBT EQUIVALENTS: Oaklawn has only limited operating leases and does not have a defined benefit pension plan, which bolsters its debt profile.
MIXED LIQUIDITY: With cash on hand of 144 days, Oaklawn's liquidity position relative to scope of operations is adequate. Pro forma cash-to-debt of 53%, however, is modest for the rating category.
SMALL PROVIDER: With less than $130 million in operating revenue, Oaklawn is considerably smaller than the 'BBB' median of nearly $450 million. Moreover, Oaklawn is surrounded by a number of larger health systems in the broader service area.
RATING SENSITIVITIES
OPERATING STABILITY EXPECTED: Given its strong market position in a good service area, very high quality scores, and operating track-record, Fitch expects Oaklawn Hospital to maintain operating EBITDA margins at levels sufficient to sustain coverage metrics consistent with the rating and to bolster liquidity ratios over time.
CREDIT PROFILE
Oaklawn is a 78-staffed bed community hospital located in Marshall, MI, at the intersection of I-94 and I-69. Marshall is located in south-central Michigan, approximately 13 miles east of Battle Creek, 36 miles east of Kalamazoo, 47 miles southwest of Lansing, and 33 miles west of Jackson. Oaklawn generated just over $125 million in operating revenue in fiscal 2016.
Market Leader with Competition in Broader Service Area
Oaklawn is the market share leader of a primary service area that covers the eastern two-thirds of Calhoun County and small portions of Eaton, Jackson, and Branch counties. The hospital faces competition in the broader area, most notably from Bronson Healthcare's Bronson Battle Creek Hospital (BBC, located approximately 13 miles west in Battle Creek). For the nine-month period January-September 2015, Oaklawn captured 32.2% inpatient market share (excluding tertiary and rehabilitation), compared to BBC with 23.7%. In 2014, the last full year for which data are available, Oaklawn captured 30.9% and BBC captured 27.2%. BBC's market share data exclude Bronson's flagship referral center Bronson Methodist Hospital (located 36 miles west of Marshall in Kalamazoo). Henry Ford Allegiance Health (a member of Henry Ford Health System) captures the number three position in the market with approximately 10% share.
Nice Rebound in Operating Margins in Fiscal 2015 and 2016
Under a new senior executive team, Oaklawn's operating margins improved noticeably in fiscal 2015 and 2016. In fiscal 2013 (March 31 year-end), Oaklawn recorded an operating margin of -2.1%, which continued in fiscal 2014 with an operating margin of -4.7%. The operating EBITDA margin measured 7.3% in fiscal 2013 and 6.8% in fiscal 2014. The losses in 2013 resulted from significant volume declines in February and March 2013 and an accounting error that was discovered at the end of fiscal 2013 that failed to reconcile correctly reimbursement offsets related to a commercial contract.
Management took corrective actions in fiscal 2014 to improve operating results. Actions included: the new CEO (who started just before the accounting issue was identified) brought on a new CFO and other key finance members; and the engagement of a turnaround consultant during 2014 who helped to improve accounts receivables, identify Lean process efficiencies, and enact other cost management initiatives including the hospital's first ever layoff. Operating performance also benefited from strong surgical volume gains resulting from a new surgery center that opened in 2012 and the recruitment of key physicians, particularly a very profitable neurosurgeon (who now accounts for approximately 10% of system revenue, suggesting a high reliance on one doctor). Despite the improvements, fiscal 2014 operating margins remained suppressed, due in part to the costs associated with the turnaround consultant.
Operating profitability improved significantly in fiscal 2015 as a result of the improvement efforts. Oaklawn's operating margin and operating EBITDA margin increased to 1.4% and 11.3%, respectively. Operating gains were sustained in fiscal 2016 with a 1.9% operating margin and 10.8% operating EBITDA margin, comparing favorably with Fitch's 'BBB' median operating and operating EBITDA margins of 1.5% and 8.7%, respectively.
Fitch expects Oaklawn to sustain operating margins at least in-line with 'BBB' medians, although not necessarily at the levels achieved in fiscal 2015 and fiscal 2016. Through five-months of fiscal 2017 (as of August 2016), the system recorded an operating margin of -0.8% and operating EBITDA margin of 8.0% (-0.9% and 8.7%, respectively, budgeted for the five-month period). Softer margins in the interim period were due to decreased inpatient admissions, a shift from commercial payors to Medicaid, and supply cost growth exceeding revenue growth. The inpatient declines were expected as a group of ortho physicians left the staff. Oaklawn subsequently has recruited replacement physicians. Fitch expects full-year fiscal 2016 operating margins to exceed five-month results.
Adequate Debt Ratios
Oaklawn's pro forma debt ratios are adequate for the rating. Based on fiscal 2016 results and including the series 2016 bonds, with a pro forma MADS of $5.1 million, MADS coverage from EBITDA equaled 3.0x and is consistent with Fitch's 'BBB' median of 3.0x. Pro forma debt-to-EBITDA is somewhat high at 5.7x relative to Fitch's 'BBB' median of 4.3x. Pro forma debt load is manageable as MADS as a percentage of revenue is 4.0% ('BBB' median is 3.6%).
After the issuance of the series 2016 bonds, Oaklawn will go from essentially all variable rate debt to all fixed rate debt. The plan of finance includes terminating Oaklawn's existing swaps with an expected termination fee of approximately $3 million. Financial covenants are expected to include minimum debt service coverage (1.10x consultant call-in, 1.00x event of default) and minimum cash on hand (60 days consultant call-in, 45 days event of default). Oaklawn also has a maximum debt-to-capitalization covenant of 60% in place through 2020 when the series 2008 bonds mature.
Oaklawn's comparative debt position is bolstered because of its lack of debt equivalents. For example, the hospital does not have a defined benefit pension plan or material operating leases.
Mixed Liquidity
At fiscal year-end (FYE) 2016, Oaklawn had just under $46 million of unrestricted cash and investments. Relative to the system's scope of operations, this translated to an adequate cash on hand of 144 days ('BBB' median is 161 days). Pro forma cash-to-debt and cushion ratio of 53% and 9.0x, however, are modest ('BBB' medians are 91% and 11.7x, respectively). Fitch expects liquidity ratios to improve over time based on expected operating results, manageable capital spending plans, and the fact that Oaklawn does not have a defined benefit pension plan.
Manageable Capital Spending
Oaklawn's capital spending plans are manageable in the coming years. The system's average age of plant measured a favorably low 9.7 years at FYE 2016 ('BBB' median is 11.6 years). Oaklawn has approximately $48 million of capital plans between FY 2017 and FY 2020, with no major "bricks and mortar" projects. This translates to a capital spending ratio of approximately 1.0x. Highlighted projects include build out of shelled operating room space, an emergency department redesign, CT and MRI investments, and land purchases for future ambulatory growth. Oaklawn does not have additional new money debt plans in the near term beyond the current issuance.
Disclosure
Oaklawn covenants to provide bondholders with annual and quarterly financial disclosure through the Municipal Securities Rulemaking Board EMMA system. Quarterly reports are to be reported by the 15th of the second month following the quarter end, while audits are to be reported within four months of the fiscal year end.
Additional information is available at 'www.fitchratings.com'.
Applicable Criteria
Revenue-Supported Rating Criteria (pub. 16 Jun 2014)
https://www.fitchratings.com/site/re/750012
U.S. Nonprofit Hospitals and Health Systems Rating Criteria (pub. 09 Jun 2015)
https://www.fitchratings.com/site/re/866807
Additional Disclosures
Dodd-Frank Rating Information Disclosure Form
https://www.fitchratings.com/creditdesk/press_releases/content/ridf_frame.cfm?pr_id=1012515
Solicitation Status
https://www.fitchratings.com/gws/en/disclosure/solicitation?pr_id=1012515
Endorsement Policy
https://www.fitchratings.com/jsp/creditdesk/PolicyRegulation.faces?context=2&detail=31
ALL FITCH CREDIT RATINGS ARE SUBJECT TO CERTAIN LIMITATIONS AND DISCLAIMERS. PLEASE READ THESE LIMITATIONS AND DISCLAIMERS BY FOLLOWING THIS LINK: HTTPS://WWW.FITCHRATINGS.COM/UNDERSTANDINGCREDITRATINGS. IN ADDITION, RATING DEFINITIONS AND THE TERMS OF USE OF SUCH RATINGS ARE AVAILABLE ON THE AGENCY'S PUBLIC WEB SITE AT WWW.FITCHRATINGS.COM. PUBLISHED RATINGS, CRITERIA, AND METHODOLOGIES ARE AVAILABLE FROM THIS SITE AT ALL TIMES. FITCH'S CODE OF CONDUCT, CONFIDENTIALITY, CONFLICTS OF INTEREST, AFFILIATE FIREWALL, COMPLIANCE, AND OTHER RELEVANT POLICIES AND PROCEDURES ARE ALSO AVAILABLE FROM THE CODE OF CONDUCT SECTION OF THIS SITE. FITCH MAY HAVE PROVIDED ANOTHER PERMISSIBLE SERVICE TO THE RATED ENTITY OR ITS RELATED THIRD PARTIES. DETAILS OF THIS SERVICE FOR RATINGS FOR WHICH THE LEAD ANALYST IS BASED IN AN EU-REGISTERED ENTITY CAN BE FOUND ON THE ENTITY SUMMARY PAGE FOR THIS ISSUER ON THE FITCH WEBSITE.
Copyright © 2016 by Fitch Ratings, Inc., Fitch Ratings Ltd. and its subsidiaries. 33 Whitehall Street, NY, NY 10004. Telephone: 1-800-753-4824, (212) 908-0500. Fax: (212) 480-4435. Reproduction or retransmission in whole or in part is prohibited except by permission. All rights reserved. In issuing and maintaining its ratings and in making other reports (including forecast information), Fitch relies on factual information it receives from issuers and underwriters and from other sources Fitch believes to be credible. Fitch conducts a reasonable investigation of the factual information relied upon by it in accordance with its ratings methodology, and obtains reasonable verification of that information from independent sources, to the extent such sources are available for a given security or in a given jurisdiction. The manner of Fitch's factual investigation and the scope of the third-party verification it obtains will vary depending on the nature of the rated security and its issuer, the requirements and practices in the jurisdiction in which the rated security is offered and sold and/or the issuer is located, the availability and nature of relevant public information, access to the management of the issuer and its advisers, the availability of pre-existing third-party verifications such as audit reports, agreed-upon procedures letters, appraisals, actuarial reports, engineering reports, legal opinions and other reports provided by third parties, the availability of independent and competent third- party verification sources with respect to the particular security or in the particular jurisdiction of the issuer, and a variety of other factors. Users of Fitch's ratings and reports should understand that neither an enhanced factual investigation nor any third-party verification can ensure that all of the information Fitch relies on in connection with a rating or a report will be accurate and complete. Ultimately, the issuer and its advisers are responsible for the accuracy of the information they provide to Fitch and to the market in offering documents and other reports. In issuing its ratings and its reports, Fitch must rely on the work of experts, including independent auditors with respect to financial statements and attorneys with respect to legal and tax matters. Further, ratings and forecasts of financial and other information are inherently forward-looking and embody assumptions and predictions about future events that by their nature cannot be verified as facts. As a result, despite any verification of current facts, ratings and forecasts can be affected by future events or conditions that were not anticipated at the time a rating or forecast was issued or affirmed.
The information in this report is provided "as is" without any representation or warranty of any kind, and Fitch does not represent or warrant that the report or any of its contents will meet any of the requirements of a recipient of the report. A Fitch rating is an opinion as to the creditworthiness of a security. This opinion and reports made by Fitch are based on established criteria and methodologies that Fitch is continuously evaluating and updating. Therefore, ratings and reports are the collective work product of Fitch and no individual, or group of individuals, is solely responsible for a rating or a report. The rating does not address the risk of loss due to risks other than credit risk, unless such risk is specifically mentioned. Fitch is not engaged in the offer or sale of any security. All Fitch reports have shared authorship. Individuals identified in a Fitch report were involved in, but are not solely responsible for, the opinions stated therein. The individuals are named for contact purposes only. A report providing a Fitch rating is neither a prospectus nor a substitute for the information assembled, verified and presented to investors by the issuer and its agents in connection with the sale of the securities. Ratings may be changed or withdrawn at any time for any reason in the sole discretion of Fitch. Fitch does not provide investment advice of any sort. Ratings are not a recommendation to buy, sell, or hold any security. Ratings do not comment on the adequacy of market price, the suitability of any security for a particular investor, or the tax-exempt nature or taxability of payments made in respect to any security. Fitch receives fees from issuers, insurers, guarantors, other obligors, and underwriters for rating securities. Such fees generally vary from US$1,000 to US$750,000 (or the applicable currency equivalent) per issue. In certain cases, Fitch will rate all or a number of issues issued by a particular issuer, or insured or guaranteed by a particular insurer or guarantor, for a single annual fee. Such fees are expected to vary from US$10,000 to US$1,500,000 (or the applicable currency equivalent). The assignment, publication, or dissemination of a rating by Fitch shall not constitute a consent by Fitch to use its name as an expert in connection with any registration statement filed under the United States securities laws, the Financial Services and Markets Act of 2000 of the United Kingdom, or the securities laws of any particular jurisdiction. Due to the relative efficiency of electronic publishing and distribution, Fitch research may be available to electronic subscribers up to three days earlier than to print subscribers.
For Australia, New Zealand, Taiwan and South Korea only: Fitch Australia Pty Ltd holds an Australian financial services license (AFS license no. 337123) which authorizes it to provide credit ratings to wholesale clients only. Credit ratings information published by Fitch is not intended to be used by persons who are retail clients within the meaning of the Corporations Act 2001